This Is MS Multiple Sclerosis Community: Knowledge & Support

David McWilliams, CEO of PharmaFrontiers Corp, recently gave an interview with StreetIQ.com on August 25, 2005. The mp3 audio file of the interview can be found here. While the interview is targeted towards investors and not a scientific audience, there is still some very encouraging news none-the-less. During the interview, David McWilliams indicates that they are obtaining a 90% reduction in relapses! In addition, he states that 40% of their patients have improved physically with an improvement in disability scores ranging from 0.5 to 3 points on a 10 point scale within 6 months, and that the treatment is "stopping the progression of the disease!"

NHE

excellent research and news! thanks for sharing

_________________
Disclaimer: Any information you find on this site should not be considered medical advice. All decisions should be made with the consent of your doctor, otherwise you are at your own risk.